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Executive Summary 
Total knee arthroplasty (TKA) and total hip arthroplasty (THA) are surgical procedures 
performed for painful, dysfunctional joints most often caused by osteoarthritis. These procedures 
are increasing in demand for not just the elderly, but young adults as well. They are elective 
procedures associated with a three to five gram decrease in hemoglobin postoperatively, 
considered a major blood loss. International research results, verified by analysis of a 228 patient 
sample from the system in this study, demonstrate that patients who enter these procedures with 
anemia are more likely to require postoperative blood transfusions. With a decreasing supply due 
to a shrinking donor pool and added costs due to stringent testing, allogeneic blood used for 
transfusions demands that providers use stewardship with this precious resource. Autologously 
donated blood as an option is falling out of favor because it further reduces the preoperative 
hemoglobin, is costly, and unused units are wasted. Blood use for transfusions, whether 
autologously donated or allogeneic, is associated with many risks including but not limited to 
fluid volume overload, delayed wound healing, postoperative infections, and longer 
hospitalizations. Anemia is an abnormal finding and, in the setting of elective surgical 
procedures with major blood loss, should be corrected preoperatively to decrease the need for 
blood transfusions.  This change project describes interventions to increase red blood cells 
preoperatively, weaving the interventions into an evidenced-based algorithm for consideration in 
practice by members of the healthcare team. The evidence-based algorithm and study findings 
will be shared with providers to invoke discussion on strategies for implementation and 
evaluation. Furthermore, this project serves as an example of research-guided changes, designed 
by a doctorally prepared nurse, capable of enhancing positive health care outcomes for both the 
patient and the healthcare system. 
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Background 
  This change project was born in a spirit of interdisciplinary inquiry. It originated in a 
dialogue between an advanced practice nurse (APN) and an orthopedic surgeon regarding the 
need for postoperative blood transfusions in patients who electively have total hip or total knee 
replacement surgeries. Areas of discussion included: differences in observed procedural blood 
loss versus postoperative hemoglobin levels; the management of preoperative anemia in this 
patient population; the risks involved with blood transfusions; and the judicious use of blood as a 
scarce resource. Questions raised by both providers inspired this research designed to clarify 
whether current practice patterns align with evidence-based practice leading to optimum 
outcomes for patients who opt to have elective total hip or total knee replacement surgeries. 
 The setting for the research is a Catholic health care system in the Midwest, which has 
multiple hospitals where orthopedic procedures are performed. This particular health care system 
has a service-based mission and vision steeped in social justice principles whereby communities 
are offered compassionate patient service and clinical excellence. This particular research study 
aligns with the system strategic goals of clinical excellence and stewardship. Clinical excellence 
is defined as valuing superior performance, exceeding expectations, seeking continuous ways to 
improve care, meeting challenges and opportunities in a creative manner, and using the best 
practices to help the organization achieve its goals with a spirit of teamwork. Stewardship is 
defined as responsible use of human, financial, and natural resources entrusted for the common 
good, with special attention to the poor.  
 A review of the literature provides the basis for clinical excellence in care of patients who 
elect to have total hip or total knee replacement surgery specifically as it relates to preoperative 
anemia and the utilization of postoperative blood transfusions. Data collection and analysis of 
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practice patterns utilized in this healthcare system for patients who have total knee arthroplasty 
(TKA) and total hip arthroplasty (THA) procedures provides real life information from which to 
compare. Analysis of results guides recommendations for appropriate, minimal, safe, and cost-
effective utilization of blood, which will help ensure that the call for stewardship is fulfilled. 
Project objectives 
  The objectives for this change project are as follows: 
1. Utilize patient data to analyze preoperative anemia and postoperative transfusions 
associated with elective THA and TKA 
2. Review relevant literature on preoperative anemia and its impact on postoperative blood 
transfusions associated with TKA and THA elective procedures  
3. Create an algorithm to address preoperative anemia for patients who elect to have TKA 
and THA surgical procedures based on identified gaps between study findings and the 
literature 
4. Stimulate interdisciplinary inquiry into health care practices by sharing this project with 
members of the orthopedic and healthcare community 
5. Fulfill requirements for a Doctorate in Nursing change project while demonstrating how 
this role can be utilized to improve patient care 
Challenges 
  Healthcare in our country is referred to as a system.  The structure of the healthcare 
system is complex in nature and not well understood. Healthcare providers, who represent what 
should be inter-connective parts of the system, often operate in isolation, devoid of 
communication with other team members. Interdisciplinary communication is critical to the 
improvement of patient outcomes. Herein lay the challenges for this change project, namely, the 
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need to stimulate system players to work together, while developing a sense of inquiry into 
practices that improve the quality of the patient experience. This particular healthcare system has 
multiple professionals at multiple sites performing these orthopedic procedures. The sites are in 
the process of becoming integrated. 
Research Questions 
 The study was designed to answer the following specific research questions: 
1. Is there a relationship between preoperative anemia and the use of postoperative blood 
transfusions? 
2. What risk factors are associated with postoperative blood transfusions? 
3. Is there a change in postoperative hemoglobin levels by surgical type over the initial 
postoperative days? 
Summary 
  Following a review of current literature and the study of a sample of surgical patients, 
this research will culminate in the design of an algorithm for preoperative care of patients with 
anemia who elect to have TKA and/or THA within this healthcare system. This practice tool will 
be shared with members of the orthopedic community for consideration. It is one of many steps, 
which, if instituted, can improve blood management for these and other elective surgical 
procedures.  
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Theoretical Framework 
  Strategizing for structural change within the organization demands a theoretical 
framework that can be applied to both the individual and the team as a whole. In order to obtain 
synergistic energy from a team, it is essential for individuals to grow in self-actualizing skills at 
the same time the team is developing mutual actualizing talents. The Human Systems theory 
represents a formula to help both individuals and team members succeed.  
 Hanlon (1968) devoted his career to the development of a Human Systems Theory to 
guide education and administration. Sinnen (1981) furthered the work of Hanlon by defining the 
profession of nursing with a nurturance theory and model based on the Human Systems Theory. 
Human Systems Theory involves seven basic human operations: learning, creation of worldview, 
creation of ideal pattern, conceptualization, climate creation, environment creation, and 
cybernetics. In the educational realm, the mastery of these processes leads to self-actualization 
for the individual.  The role of the educator is to assist the individual in this process of mastery. 
Likewise, the mastery of these same seven human processes at the group level leads to 
synergistic behaviors. The role of the administrator is to assist groups to reach this level of 
actualization. The role of the advanced practice nurse is that of the educator, nurturing patients 
toward mastery of these seven human operations. Additionally, the advanced practice nurse is 
prepared to assume the role of administrative leader assisting healthcare teams to actualize 
common learnings which inform the operations of worldview and ideal pattern construction so 
that decision making, problem solving, planning, and evaluation (conceptualization) can be 
accomplished for the benefit of improvements in patient care. With that common foundation, the 
operations of creating a climate and environment specifically designed for the patient by the 
healthcare team can become a reality. The work involved in creating a healthcare team that can 
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actualize, in essence, practice at the level of cybernetic mastery is intense, but so are the rewards 
for all involved with results benefiting patient care. 
 The absence of this administrative leadership is evident in health care today. 
Fragmentation of care, failure to institute best practice measures into care, inconsistent 
outcomes, and lack of coordinated communication between health care team members are some 
of the more noted observations. In order to improve healthcare, it is imperative that health care 
leaders understand and work with teams to actualize the seven basic operations. It is only 
through such strategies that systems of care and patient outcomes will experience lasting 
improvements. 
 This project seeks to increase teamwork involved in the care of patients who elect to have 
THA or TKA. The focus is improving systems of care involved in anemia management for this 
group of patients. The goal is to stimulate team learning and create a common worldview woven 
from inquiry, a common ideal pattern, common conceptualization within a climate, and an 
environment consistent with optimal patient outcomes.  After comparing best practice standards 
recommended in the literature with current practice patterns, it will be up to the team to make 
decisions based on analysis of identified discrepancies, to initiate appropriate changes, and to 
develop a plan to evaluate the results while moving forward with further inquiries into practice. 
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Review of the Literature 
  Paramount to improving systems to manage preoperative anemia for patients who 
electively have TKA or THA procedures is an understanding of pertinent literature. This review 
of the literature explores preoperative anemia, TKA and THA procedures, and the impact of 
preoperative anemia on the utilization of blood transfusions in the postoperative phase of patient 
care.  
Significance of Preoperative Anemia  
 Anemia is defined as lack of sufficient healthy red blood cells in the body and is detected 
by serum hemoglobin levels (National Anemia Action Council, 2009). Hemoglobin is 
responsible for carrying oxygen from the lungs throughout the body. Anemia can be acute 
accompanying a major episode of bleeding or chronic as seen with slower bleeds, vitamin or iron 
deficiencies, and in association with chronic disease (National Anemia Action Council, 2009). 
Symptoms depend on the degree of anemia and may include fatigue, shortness of breath or chest 
pain with exertional activities, dizziness, anorexia, or depression (National Anemia Action 
Council, 2009). Signs of anemia can include pale skin, brittle nails, coldness of extremities, 
murmur, and irregular heartbeats (National Anemia Action Council, 2009).  Mild forms of 
anemia respond easily to treatment while more severe and long lasting forms left undiagnosed 
and untreated can be life threatening (National Anemia Action Council, 2009). The World 
Health Organization (2008) identifies anemia as a hemoglobin level of less than 13 g/dL in adult 
men and less that 12 g/dL in adult non-pregnant females. Iron deficient anemia (IDA), the most 
prevalent form of anemia, has been associated with delayed cognitive development and poor 
physical performance. IDA is a major factor contributing globally to the burden of disease 
(World Health Organization, 2008).  In an analysis of the literature on IDA, Killip, Bennett and 
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Chambers (2007) elaborate on causes stemming from inadequate dietary intake of iron, 
malabsorption of iron, or losses in women of reproductive age. They link IDA prevalence to 
gender and ethnicity, reporting a prevalence of 2% in adult men, 9-12% in non-Hispanic white 
women, and nearly 20% in Black and Mexican-American women (Killip, et al., 2007 p. 675). 
Anemia is more common in the elderly but it is not a consequence of the normal aging process 
(Holdener & Liang, 2007). Anemia is an abnormal laboratory result reflective of a clinical 
condition that warrants attention. 
Anemia represents a substantial economic burden. In a study designed to examine the 
economic impact of anemia, Ershler, Chen, Reyes and Dubois (2005) looked at a managed care 
patient population and compared patients with anemia associated with six identified chronic 
conditions with patients in a nonanemic cohort. Direct and indirect health care costs as well as 
impact of work productivity were calculated and, once demographic differences were adjusted 
for, those with anemia had substantially higher costs. Based on the results, the authors estimated 
that per one million lives, those with anemia related to these identified chronic conditions incur 
$110 million greater costs. Those responsible for the care of patients with anemia are urged to 
identify and correct this condition for both clinical and economic reasons (Ershler, et al., 2005). 
The World Health Organization (2008) defines anemia as less than 12.0 g/dL for females 
as and less than 13.0 g/dL in males.  Preoperative hemoglobin levels greater than 13.0 g/dL for 
TKA and THA correlate to fewer transfusions. Keating, Meding, Faris, and Ritter (1998), 
conducted research in an effort to better understand factors associated with transfusions for 
patients who electively have knee replacement surgery. The results of this study demonstrated 
that preoperative hemoglobin levels, pre-donation hemoglobin levels, and estimated blood 
volume negatively correlate with risk of transfusions for patients in both unilateral and bilateral 
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knee replacement surgeries. Joint replacement surgery involves significant blood loss. A drop in 
hemoglobin level of 3.85 g/dl was associated with unilateral knee surgery, while those who had 
bilateral knee replacement surgery experienced an average hemoglobin drop of 5.42 g/dL. The 
patient group with preoperative hemoglobin levels greater than 13 g/dL had only an 8% chance 
of transfusion. Those considered anemic with preoperative hemoglobin levels less than 13 g/dL 
had a 30 % chance of transfusions. Patients who donated autologous units prior to surgery had an 
11.6 % chance of receiving allogeneic transfusions and a 50% chance of receiving their 
autologous units (Keating, et al., 1998). 
Preoperative anemia has been associated with poor patient outcomes including death. 
Anemic elderly patients with underlying cardiovascular disease are notably at higher risk of 
complications (Kumar & Carson, 2008). Prudent preoperative care involves a thorough history 
and physical, diagnostic testing for evaluation of cause of anemia, and correction of the condition 
(Kumar & Carson, 2008.) It is recommended that a hemoglobin level is obtained thirty days 
before the surgical procedure with a thorough analysis of unexplained anemia leading to 
postponing of elective surgery if necessary (Goodnough, et al., 2005).  
Total Hip and Total Knee Arthroplasty 
 Total hip arthroplasty (THA) and total knee arthroplasty (TKA) are elective surgical 
procedures done to relieve chronic pain, recover joint function, and improve quality of life for 
those who suffer from joint failure caused by osteoarthritis (OA), rheumatoid arthritis (RA), or 
other chronic inflammatory processes (Liang, et al., 1986). The demand for these procedures is 
increasing. In a 2007 update of adult reconstructive surgical procedures, Lonner and 
Deirmengian (2007) noted a 400% increase in TKA procedures from 1971 to 2003, with 
adjustment for age and gender. Total hip arthroplasty procedures during that timeframe increased 
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by 55%. Projections include a 600% increase in TKA and 137% for THA procedures, between 
2005 and 2030. This review also noted that osteoarthritis has replaced rheumatoid arthritis as the 
predominate diagnosis for THA and TKA procedures, while a younger patient population is 
being treated, with the largest percentage of increase seen in those less than fifty years of age 
(Lonner & Deirmengian, 2007). Anticipating the increase in numbers of patients seeking these 
surgical procedures it becomes important to focus on economic resources and improvements in 
operational efficiencies (Lonner & Deirmengian, 2007). 
 One of the greatest challenges to improving operational efficiencies and enhancing 
patient outcomes for THA and TKA procedures involves the management of associated blood 
loss. While visible blood losses are recorded, the numbers underestimate true losses. The term 
‘hidden losses’ has been coined to describe additional blood losses accounting for the drop in 
hemoglobin levels seen postoperatively. In a review of 324 patient charts from 1987 through 
1989, calculated blood losses of 3.2 + 1.3 units for a primary THA and 4.0 + 2.3 units for 
revision procedures were noted. These losses were associated with transfusion rates of 2.0 + 1.8 
units for primary and 2.9 + 2.3 units for revision THA procedures (Toy, Kaplan, McVay, 
Strauss, & Stehling, 1992). Similarly, TKA procedures have hidden losses. Primary TKA are 
linked to a 3.0 gm/dl drop in hemoglobin (Sehat, Evans, and Newman, 2004). The average 
patient loses about 4 grams of hemoglobin after THA or TKA according to Keating and Ritter 
(2002). 
 Transfusions add to the already high costs associated with these joint replacement 
procedures. In reviewing the financial impact for primary TKA procedures, Cook, Warren, 
Ganley, Prefontaine and Wylie (2008) noted Center for Medicare & Medicaid Services (CMS) 
reimbursed over $2 billion in 2006. Of further concern is that CMS reimbursement is less than 
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actual hospital bills, forcing some institutions to disallow these procedures from their list of 
services due to the unfavorable finances (Cook, Warren, Ganley, Prefontaine & Wylie, 2008). 
Transfusions  
Elective surgeries that involve major blood loss can involve critical decision making 
regarding the use of blood transfusions. The use of blood transfusions is unavoidable under 
certain circumstances, there are clinical and financial reasons mandating a closer examination of 
the use of transfusions with elective surgical procedures (Lemaire, 2008). The use of allogeneic 
transfusions in elective procedures is of concern because, in parts of the country, blood is a 
scarce resource with a notable shrinking donor pool. With the number of surgical patients on the 
increase, decisions to transfuse require careful consideration by all members of the surgical team 
(Monk, 2004). The blood supply is notably safer due to stringent testing, yet, blood transfusions 
are associated with adverse effects, including but not limited to, transfusion reactions, 
transmission of infectious disease, transfusion related acute lung injury, administrative errors, 
and currently unknown side effects (Lemaire, 2008). There are concerns that blood transfusions 
cause immunosuppression, thought to increase the risk of postoperative infection, delay wound 
healing, and prolong hospitalization. The medical community believes that the risk of 
immunosuppression from transfusions is real and linked with adverse clinical outcomes (Spahn 
& Casutt, 2000). These concerns have resulted in a process of leukocyte depletion for allogeneic 
blood (Slappendel, Dirksen, Weber & van der Schaaf, 2003). Leukocyte depletion is a process 
aimed at meditating the effects of allogeneic transfusions on the immune system. Additional 
research is investigating the changes that red blood cells undergo when exposed to cold storage. 
Koch, et.al., (2008) compared the effects of old blood, stored more than 14 days, with newer 
blood on 2872 patients who had cardiac surgery and required transfusions. The findings 
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demonstrated a significant increase in the risk of postoperative complications and in short-term 
and long-term mortality in those who were transfused with blood stored longer than two weeks 
(Koch, et. al, 2008). 
There are two forms of blood transfusions. Autologous blood is donated by patients in 
advance of their surgical procedure, placed in cold storage, and transfused back if and when 
needed.  Allogeneic, the most common type of transfusion, is donated, undergoes rigorous 
testing, and is placed in cold storage and made available to the public. All blood transfusions 
have associated risks and can be correlated with a greater chance of infection, fluid overload, and 
prolonged hospital stays (Kumar, 2009). The surgical team is urged to use interventions that limit 
transfusions, conserve blood, and correct preoperative anemia in order to improve surgical 
outcomes (Monk, 2004). To that end, the concept of “bloodless medicine” has become more 
popular (Kickler, 2003). “Bloodless medicine” refers to clinical strategies for patient care 
designed to avoid allogeneic blood transfusions (Goodnough, Shander, & Spence, 2003). It is 
one area of blood management programs that have been established worldwide (Kickler, 2003). 
Blood management techniques have grown because of treating patients who have refused blood 
products due to religious beliefs (e.g. Jehovah witness) or other reasons. This has stimulated a 
belief that minimizing transfusions represents quality and safe care that should be available to all 
patients (Shander & Goodnough, 2006). Blood conservation strategies are described as falling 
within three pillars of impact: those interventions which augment preoperative red blood cell 
mass; those interventions which reduce surgical blood loss; and, the acceptance of lower 
hemoglobin levels (Gombotz, Rehak, Shander, & Hofmann, 2007). 
Autologous blood donation. Autologous blood donation (PAD) is a controversial option 
to blood management for patients who electively have THA or TKA procedures. While still an 
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option, there is growing concern related to the inconvenience, cost, waste, and preoperative 
anemia associated with this intervention (Pierson, Hannon, & Earles, 2004). Unused autologous 
units cannot enter the blood center supply because of policy and laws. Therefore, unused PAD 
units are wasted, leading to concerns about efficient resource utilization. Autologous transfusions 
hold the same risk profile of allogeneic transfusions. These include administration errors, risk of 
postoperative infection, fluid overload, and the risks associated with impair red blood cells 
altering the delivery of oxygen to tissues, potentially adding to the systemic burden of 
inflammation (Boucher & Hannon, 2007). 
Keating and colleagues (1998) reviewed the hospital records of 279 patients who had 
either unilateral or bilateral knee replacement procedures. The sample included patients who 
participated in the autologous donation program and those who did not. Those who participated 
in the autologous donation program had a notable 76% of their donated blood wasted. A logistic 
regression analysis was performed on a variety of data elements to determine the independent 
predictors for transfusions for this patient population. This research culminated in the design of a 
critical pathway with specific emphasis on correction of preoperative anemia as the most 
important factor influencing the use of allogeneic blood transfusions in knee replacement 
surgeries (Keating, et al., 1998). 
Similarly, Hatzidakis, Mendlick, McKillip, Reddy, and Garvin (2000) sought to analyze 
risk factors for allogeneic transfusions and appropriate strategies for the use of autologous 
donation in total joint arthroplasty in their Nebraska setting. Employing a retrospective chart 
audit of 489 consecutive patients who had total joint arthroplasty procedures and logistic 
regression analysis of several factors, they were able to clarify patients at lowest risk of 
transfusions.  Like the other studies, lower preoperative hemoglobin was associated with the 
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need for allogeneic transfusions. The results link the type of surgery performed, age of the 
patient, and the preoperative hemoglobin level as factors for identifying those at most risk for 
transfusions with total arthroplasty procedures. Patients with minimal risk of needing 
transfusions have higher initial hemoglobin (130 to 150 grams per liter), are less than sixty-five 
years of age, and are scheduled for primary joint replacement surgery. While the authors 
continue to recommend the use of PAD, patients in the minimal risk category are provided better 
information to aid in deciding if the PAD program is worth the associated effort (Hatzidak, et al., 
2000). 
Using prospective, randomized methodology, Billote, Glisson, Green and Wixson (2002) 
studied patients scheduled for primary total hip surgery with a preoperative hemoglobin level > 
120 g/L, dividing a group of 96 into those who donated autologous units and those who did not 
donate. There were no significant differences noted in demographics of the donors and non-
donors or blood-loss volumes associated with the surgical procedures. Neither group required an 
allogeneic transfusion. Twenty-nine of the 42 patients (69%) who participated in PAD received 
an autologous transfusion postoperatively. The authors concluded that for nonanemic patients 
undergoing a primary total hip surgery there is no benefit in PAD, in fact donation increased the 
use of autologous transfusions, wasting of units, and the cost associated with the procedure 
(Billote, et al., 2002). 
  PAD programs remain in vogue for elective surgery due to public perception that the 
allogeneic blood supply is unsafe. When used inappropriately, PAD contributes to preoperative 
anemia which is the most important factor linked to postoperative transfusions. PAD units may 
be transfused perioperatively simply because they are available, not necessarily because they are 
needed. It is important for providers to understand the evidence and published guidelines behind 
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PAD as a practice option, to utilize it with careful preoperative planning, and to help educate the 
public on the economic impact involved in this process (Keating & Meding, 2002). While the 
practice of PAD is on the decline, it is still considered a useful option in those with multiple 
antibodies making donor blood difficult to obtain (Kumar, 2009). 
The Impact of Anemia on Recovery 
The postoperative period for some patients who have TKA or THA procedures includes 
admission to an inpatient rehabilitation unit to maximize function of the joint in a supervised 
setting. Lower hemoglobin levels affect the patient’s ability to participate in physical therapy. 
This was the research topic of a retrospective study of 184 patients admitted to an acute 
rehabilitation facility from 2001 to 2003. The study, funded by Ortho Biotech, measured patient 
function using the Functional Independence Measure (FIM) Instrument and through multivariate 
analysis, correlated length of stay, hemoglobin levels, and changes in FIM scores (Diamond, 
Conaway, Mody, & Bhirangi, 2006). Findings from this study verify that a higher baseline 
hemoglobin level is associated with a shorter length of stay and faster functional gains. While 
additional studies such as this one are recommended, the results further confirm that strategies, 
which limit blood loss and increase hemoglobin levels in this population affect the entire patient 
experience (Diamond, Conaway, Mody, & Bhirangi, 2006). Of concern are the interventions that 
help maximize hemoglobin levels in a safe, efficient, and cost effective manner. 
Summary 
 Anemia is an abnormal condition that influences the quality of life for many persons and 
preoperatively leaves patients vulnerable for postoperative transfusions. Those found to be at 
greatest risk include women, particularly Black and Mexican-American women, the elderly, and 
those with chronic comorbid conditions. Transfusions are associated with complications, costs, 
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and longer hospitalizations. TKA and THA are surgical procedures electively selected by 
patients to improve mobility, functionality, and quality of life. These procedures are associated 
with major blood loss. Optimizing preoperative hemoglobin levels decreases the chance for 
transfusions in the postoperative surgical phase of TKA and THA procedures. 
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Project Design and Methodology 
Project Design 
This descriptive change project was designed to examine preoperative anemia and 
postoperative transfusions associated with elective THA or TKA procedures for patients in one 
system, to compare findings to recommendations in relevant literature, and to make 
recommendations for practice changes based on a gap analysis. The setting for this study was a 
Midwest multi-hospital health care system. A retrospective chart audit was the method used to 
collect data to examine the relationship between preoperative anemia and postoperative blood 
transfusions, to identify other risk factors associated with postoperative blood transfusions, and 
to ascertain if there is a change in hemoglobin levels associated with these procedures in the 
initial postoperative days. 
Approval for this study was obtained from the Institutional Review Boards (IRB) of St. 
Catherine University as well as the healthcare system prior to beginning the data collection 
portion of the research study.  The study was retrospective in nature. The information technology 
department (IT) completed a data search. The results of this search identified patients who 
elected to have TKA or THA procedures at one of three acute care sites within the healthcare 
system over a three-month timeframe between January 1, 2009 and March 31, 2009. The total 
number of patients noted from the initial data pull was 235 patients, of which 228 patients met 
inclusion criteria. Patients age eighteen and older who had unilateral or bilateral, primary or 
revision total knee or total hip surgical procedures were included in the database. Several 
patients had only partial procedures and were therefore excluded. Informed consent for 
participation in this research was incorporated into the signed surgical consent.  The consent 
gives permission for medical education or scientific research as long as the patient cannot be 
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identified in the research. It is assumed that the consent form was reviewed in a patient exchange 
prior to surgery and that the patient fully understood the information.  
A review of the literature revealed the data elements worth collecting. A codebook for 
data collection was designed using the identified variables (see Appendix A). These elements 
include patient demographics, pre and postoperative hemoglobin and hematocrit levels, number 
of autologous or allogeneic blood transfusion utilized, length of stay, and financial data 
associated with the hospitalization for the surgical procedures. An associate from the data 
management department assisted in the development of excel spreadsheets for the data collection 
process. The author of the change project was the sole person involved in collecting the data. The 
medical record number was the only patient identifier extracted from the electronic health chart. 
A code number was assigned to each medical record number, after which the medical record 
column was removed from the data set. A sheet containing the medical record number-code 
number match is retained in a locked cabinet in the principal investigator’s office. This was 
separated from the data analysis spreadsheet and analysis run sheets, and kept in a password 
protected on-line folder. Only the principal investigator had access to the medical record number 
information. Once the study was completed, the medical record-code number match sheet was 
destroyed. The data used for analysis are secured and will be maintained by the principal 
investigator for seven years, in accordance with IRB policy. 
Methodology 
  Statistical Package for the Social Sciences (SPSS) program was used for data analysis.  
The three research questions were analyzed in the following manner (Table 1):  
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Table 1 Methodology for Analysis of Research Questions 
 
Research Questions Data Analysis 
Is there a relationship between preoperative 
anemia and the use of postoperative blood 
transfusions? 
Chi square analysis 
 
What risk factors are associated with 
postoperative blood transfusions? 
Chi Square analysis 
Is there a change in postoperative hemoglobin 
levels by surgical type over the initial 
postoperative days? 
Repeated measures general linear model 
analysis 
 
Methodology for Enacting the Change Process 
Key stakeholders are being informed of the findings and additional champions of the 
change process are being identified. Results are being disseminated to interdisciplinary 
colleagues with the goal of defining action steps for implementing the algorithm into practice. 
Ongoing utilization of transfusions with TKA and THA will be aligned with the quality 
department so that results of the change can be monitored. Additionally, in sharing this research, 
it is hoped that team members will be stimulated to make other inquires into practice so that the 
work of enhancing the patient experience is continually maximized and validated with evidenced 
based knowledge. 
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Data Analysis  
 This study sample included 228 surgical patients who had either TKA or THA 
procedures within a three-month timeframe at one of several acute facilities in a Midwest 
healthcare system. Demographic data for the patients in this retrospective study are synchronized 
in Table 2. The sample was made up of one hundred and fifty-seven (69%) females and seventy-
one (31%) males ranging in age from 26 to 90 years of age with a mean age of sixty-five years. 
The age variable was further grouped as listed in the table. The majority of the patients were 
Caucasian / White (86%), had underlying hypertension (73%), and had total knee procedures 
(66%). Some of the variables were reduced to dichotomous groupings due to limited numbers. 
Table 2 Sample Population Demographics and Factors                                                      
Characteristics Means Ranges N % 
Length of stay (in days) 3.35 
 
1 - 8   
Preoperative weight 90 kg 
 
46 –210kg   
Age 
Categories: 
< 50 
51-65 
66-79 
                    80 + 
65.1 
 
26 – 90 
 
 
 
          21 
93 
92 
22 
 
 
          (9) 
(41) 
(40) 
(10) 
Gender 
  Males 
  Females 
   
71 
157 
 
(31) 
(69) 
Surgical  procedures 
Hip procedures 
Knee procedures 
Categories: 
Unilateral (primary)THA 
Unilateral (primary)TKA 
Revision hip (RH) 
Revision knee (RK) 
Bilateral hip (BH) 
Bilateral knee (BK) 
   
77 
151 
 
          73 
139 
4 
           9 
0 
3 
 
(34) 
(66) 
 
         (32) 
(61) 
(2) 
          (4) 
          (0) 
          (1) 
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Co morbid conditions 
Cardiovascular Disease   68 (30) 
Hypertension   167 (73) 
Rheumatoid arthritis   7 (3) 
Diabetes Mellitus   42 (18) 
Chronic Kidney Disease   21 (9) 
Pulmonary Disease   51 (22) 
Cancer   24 (11) 
Hematological Disease   11 (5) 
Liver Disease   6 (3) 
Gastrointestinal Bleed   5 (2) 
Neurological / 
Cerebral Vascular Accident 
  12 (5) 
Preoperative medications 
Immunosuppressive agents   3 (1) 
Anticoagulation agents   17 (8) 
Epoetin alfa   0 0 
IV or oral iron   20 (9) 
IM or oral B12   14 (6) 
Folic acid   11 (5) 
 
Findings by Research Question 
Research question 1. Was there a relationship between preoperative anemia and the use 
of postoperative blood transfusions? Anemia was defined as females with a hemoglobin level 
less than 12.0 g/dL and males with a hemoglobin level less than 13.0 g/dL. Using a Chi Square 
analysis, the findings support a statistically significant relationship between preoperative anemia 
and the use of postoperative blood transfusions in this patient sample. Of the 40 subjects who 
were anemic, 30 (75%) were treated with postoperative blood transfusions (χ 2= 33.93; p< .001), 
as shown in Table 3 and further illustrated in Figure 1. Of the 188 subjects without preoperative 
anemia, 50 (26.6%) were transfused. There was no identified standard protocol for postoperative 
transfusion criteria. 
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Table 3 Chi Square Analysis of Relationship between Preoperative Anemia and Postoperative 
Transfusions 
χ
2 = 33.93, p < .001 
 
 
Figure 1 Comparison of Preoperative Anemia to Postoperative Transfusions 
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Transfusions in the sample. As illustrated in Figure 2, eighty patients (35%) of the 
                      Preoperative Anemia n (%) 
             No                                 Yes 
 
          Total 
Transfused 
Postoperatively  
                                 No 
        
           
            138 (73.4) 
    
 
10 (25) 
           
         
          148 (64.9) 
                                Yes              50 (26.6) 30 (75)              80 (35.1) 
Totals            188         40            228 
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sample received blood transfusions in the hospital during the postoperative period. Twenty-four 
patients (10%) participated in the autologous donation program and donated either one or two 
units preoperatively.  Twenty-one (9%) patients donated two units. Twelve (5%) patients 
received both units, four (1.8%) patients received one unit, and five (2%) patients did not receive 
any PAD units in the postoperative period. Three (1.3%) patients donated and received one PAD 
unit postoperatively. In total, forty-five units of PAD blood were donated, 68% of these were 
transfused while fourteen (31%) of these units were not transfused and therefore, wasted. 
Sixty-two patients (26%) were transfused with allogeneic blood following their surgery. 
Thirty (13%) patients received one unit; twenty-five (11%) were transfused with two units; four 
(1.8%) patients required three units while one patient each was transfused with four, five and six 
units. 
Two (1%) patients who had participated in the PAD program received their two units in 
return and required an additional allogeneic unit. 
Figure 2:  Detail of Postoperative Transfusions in Total Hip and Total Knee   
 
Not  Transfused versus Transfused (n=228)
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Research question 2.What risk factors were associated with postoperative blood 
transfusion? Chi Square tests were completed on each of the demographic and factor variables on 
transfusions. Significant results were found in several areas. Female gender significantly Surgical Subjects 
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impacted postoperative transfusions (χ 2= 4.29, p=.038).  Older age was also a factor in 
postoperative transfusions (χ 2= 7.88, p=.049).  Fifty one percent of the patients who received a 
transfusion were in the age range of 66 to 79 years. Length of stay indicated blood transfusion 
was not associated with longer stays (χ 2 =13.57, p<.001). There was a statistical significance 
between having a hematological comorbid condition and receiving postoperative transfusion (χ 2 
=4.13, p=.042). Diabetes Mellitus as a co morbid condition, while not statistically significant, 
does point to a relationship factor for transfusions. A borderline statistically significant 
relationship was also noted between those not using preoperative iron and the need for a 
postoperative blood transfusion (χ 2 =3.81, p=.051).  
Table 4 Chi Square Analysis of Selected Factors Compared to Postoperative Blood Transfusion 
Use 
 
Demographic and 
risk factors 
Transfused n 
(%) 
No 
Transfused n  
(%) 
Yes 
Totals N=228 
(%) 
χ
 2 
Age Groups 
< 50 
51-65 
66-79 
80+ 
 
16 (10.8) 
68 (45.9) 
51 (34.5) 
13 (8.8) 
 
5 (6.3) 
25 (31.3) 
41 (51.3) 
9 (11.3) 
 
21 (9.2) 
93 (40.8) 
92 (40.4) 
22  (9.6) 
 
 
 
7.88, p=.049 
Gender 
Female 
Male  
 
95 (64.2) 
53 (35.8) 
 
62 (77.5) 
18 (22.5) 
 
157 (68.9) 
71   (31.1) 
 
4.29, p=.038 
Length of Stay 
Short 1-3 days 
Long 4+days 
 
113 (76.4) 
35 (23.6) 
 
42 (52.5) 
38 (47.5) 
 
155 (68) 
73  (32) 
 
13.57, p<.001 
Hematological 
disease      
                 no 
                yes 
 
 
 
144 (97.3) 
4 (2.7) 
 
 
73 (91.3) 
7   (8.8) 
 
 
217 (95.2) 
11  (4.8) 
 
 
4.13, p=.042 
Diabetes mellitus 
                no 
                yes 
 
126 (85.1) 
22 (14.9) 
 
60 (75) 
20 (25) 
 
186 (81.6) 
42 (18.4) 
 
3.55, p=.060 
IV or oral iron                   
                no 
               yes 
 
139 (93.9) 
9 (6.1) 
 
69 (86.3) 
11 (13.8) 
 
208 (91.2) 
20  (8.8) 
 
 
3.81, p=.051 
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Research question 3. What was the rate of change in postoperative hemoglobin levels by 
surgical type over the initial postoperative days? A general linear model was used to compare 
preoperative hemoglobin lab results with postoperative sequential hemoglobin lab results for hip 
and knee subjects. There exists heterogeneity in the measures of within subject effects; therefore, 
the Huynh-Feldt statistic was used to detect the effect. The observed F ratio was statistically 
significant F (2,103) = 58.67, p < .001. In comparing TKA and THA surgical procedures in this 
patient sample, there is no statistically significant difference in hemoglobin levels in the 
postoperative period. However, there is a statistically significant decrease in hemoglobin levels 
in both surgical procedures from baseline hemoglobin levels to a nadir hemoglobin level on 
postoperative day three. As depicted in Figure 3, the hemoglobin levels for hip and knee 
procedures reach a nadir on postoperative day three dropping approximately four grams. 
Figure 3 Comparisons of Preoperative Hemoglobin Lab Results to Postoperative        
Hemoglobin Lab Results for Total Hip and Total Knee Surgical Subjects 
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Discussion of Results, Practice Algorithm, and Implications 
Discussion of Results  
The utilization of blood transfusions for elective TKA and THA is not a novel theme 
isolated to this particular healthcare system; it continues to be a topic of research globally. This 
sample of 228 patients who elected to have TKA and THA surgical procedures in this Midwest 
healthcare system in the timeframe of January 1, 2009 through March 31, 2009 experienced 
results similar to those reported in the current literature.  The prevalence of anemia in elective 
surgical patients is estimated to be 75% is some populations with a wide range from 5% to 76% 
according to the literature (Goodnough, et. al., 2005; Kumar, 2009; Saleh, McClelland, Hay, 
Semple, & Walsh, 2007).  Forty patients (18%) in this sample were noted to have preoperative 
anemia as defined by the WHO criteria, a conservative number. While WHO criteria are 
recommended to assess anemia, a hemoglobin level of 13.0 g/dL or greater is suggested as a 
starting point for those who elect to have TKA and THA procedures (Keating, et al., 1998). 
Applying 13.0 g/dL as the baseline hemoglobin level for men and women would likely result in a 
larger number of patients in this sample who qualify for preoperative interventions. An estimated 
35% of those scheduled to have elective TKA and THA procedures have preoperative 
hemoglobin levels less that 13.0 g/dL, nationally (Goodnough et. al, 2005). 
Preoperative anemia is associated with a higher risk of postoperative transfusions 
(Keating, et. al., 1998). Similarly, 75% of those noted to have preoperative anemia within this 
sample, received a transfusion in the postoperative phase. In addition to preoperative anemia and 
autologous donations, age may be a factor in predicting postoperative transfusions for patients 
who elect to have TKA and THA procedures (Hepinstall, Colwell, & Macaulay, 2003). This 
study demonstrated that female gender, age over 66, known diagnosis of anemia, lack of 
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preoperative iron supplementation, and to a lesser degree a comorbid diagnosis of diabetes 
mellitus were factors associated with postoperative blood transfusions. 
Total knee arthroplasty and total hip arthroplasty procedures are associated with major 
blood losses seen in a 3 to 5 gram hemoglobin decrease postoperatively (Keating, & Ritter, 
2002). Falling in line with the literature, the results from this study sample demonstrated an 
average decrease in hemoglobin level for TKA from 13.38 g/dL preoperatively to a nadir of 9.34 
g/dL, a 4.04 g/dL loss. For the patients having THA procedures the average hemoglobin decrease 
is 13.50 g/dL to 9.39 g/dL, a 4.11 g/dL drop. The literature supports longer hospitalizations for 
those patients who receive postoperative transfusions (Bierbaum, et al., 1999). However, even 
with this hemoglobin drop from preoperative to postoperative day three, and the resulting thirty-
five percent transfusion rate, the length of stay in the study sample favors three days over a 
longer hospitalization.  One way to decrease the costs associated with these procedure is to 
reduce the hospital stay. Further research is needed to determine how that shortened length of 
stay in the acute setting influences patient and financial outcomes for the entire episode of care.  
The data from this study may not be generalizable due to the ethnicity of the surgical 
subjects. The fact that this sample is comprised of mostly Caucasian women is intriguing and 
raises another set of research questions, especially when this particular healthcare system is 
located near a large metropolitan area with a diversified population. This is of further interest 
because TKA and THA are elective procedures, increasing in frequency, performed for pain and 
immobility related to joint failure most commonly for arthritis; incongruently, arthritis is noted to 
have a disproportionate burden  in minority populations, women, the elderly, and those 
compromised due to a lack of education, employment, and income (Marks & Allegrante, 2007). 
Arthritis is a condition associated with chronic pain and physical impairment, often robbing 
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persons of the mobility essential to availing oneself of societal goods, and thus impacting access 
to health and health care (Mackenzie, Miller, & Fins, 2005, p.7).  Healthcare providers from an 
ethical perspective of justice share the responsibility of alleviating pain and functional limitations 
associated with diseases such as arthritis, thus promoting the common good in all communities.  
 Gap analysis. Taking into account the study results and literature, there are opportunities 
to improve the care for patients who elect to have TKA and THA procedures within this 
healthcare system. Identified gaps highlighting the need for change include: 
• The lack of assessment and correction of preoperative anemia leading to the need for 
 postoperative transfusions - a patient safety issue 
• Allowances for autologous donation (PAD), a practice that is being discouraged due 
to its association with increased preoperative anemia, high costs and wastage - a 
resource utilization issue,  and, as with all transfusions, patient safety issues 
• The use of allogeneic blood transfusions, without a clearly defined blood 
conservation protocol -  a matter of distributive justice, resource utilization,  
stewardship, and evidenced based quality care 
Creating a Practice Algorithm 
Algorithms. Practice tools, such as algorithms can be designed to guide decisions to 
correct preoperative anemia and thereby decrease postoperative transfusions in patients who 
elect to have TKA and THA procedures. In the overall scope of a blood management program, 
the utilization of algorithms may seem minuscule. Nel (2008) notes that  it is better to start with 
an elementary approach designated to be modifiable, while crafting a culture of continuous 
quality improvement with the goal of safe and efficient use of the blood supply. 
In fact, there are many examples of algorithms and pathways being successfully used 
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globally to change practice patterns.  Goodnough and colleagues (2005) developed a pathway as 
a multidisciplinary physician group to assist in the process of detecting, evaluating, and 
managing preoperative anemia. It begins with a complete blood count and differential thirty days 
preoperatively. Any abnormal hemoglobin level is evaluated according to the cell indices, and 
strategies to rectify the anemia are taken. Interventions to correct anemia are based on the 
underlying cause and may include vitamin B12 injections, oral or intravenous iron 
supplementation, and/or consultative services with gastroenterologists or nephrologists 
(Goodnough, et al., 2005) 
 In a 2005 review of blood management issues associated with total joint arthroplasty, 
Callaghan, O’Rourke, and Liu, shared an algorithm from their practice adapted from Pierson, 
Hannon, and Earles (2004). The algorithm outlines options individualized for the patient. Based 
on the preoperative hemoglobin and the anticipated surgical procedure, expected hemoglobin 
losses are calculated which offer the lowest predictable postoperative hemoglobin level. With a 
threshold of 8.0 g/dL, preoperative interventions of autologous donation or epoetin alfa 
injections are recommended based on the calculated lowest hemoglobin level. This approach 
allows for current scientific information regarding blood management for total joint surgeries to 
be applied in a patient-specific manner (Callaghan, O’Rourke, & Liu, 2005). 
 Development and impact of a one-page flow chart to guide blood transfusions practice in 
total joint patient experiences was the focus of study in Switzerland by Müller, Exadaktylos, 
Roeder, Pisan, Eggli, and Jüni (2004). The flow chart was simple in design, widely distributed, 
endorsed by local leaders, and developed by the staff, which added to the ownership. The 
practice changes seen with the flow chart demonstrated a decrease in allogeneic transfusions 
from 35% to 20% and a decrease in the use of autologous blood from 29% to 6% (Müller, 
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Exadaktylos, Roeder, Pisan, Eggli, & Jüni, 2004). 
In France, Martinez, Monsaingeon-Lion, Cherif, Judet, Chauvin, and Fletcher (2007) 
developed and successfully used an algorithm as part of a quality improvement program to yield 
a 50% decrease in postoperative transfusions.  The algorithm consisted of calculation of expected 
losses with the surgical procedure and tolerated losses expressed in a mathematical equation. If 
the calculation resulted in expected losses being greater than the tolerated losses for the 
individual patient, then a transfusion-sparing procedure was recommended. Interestingly, the 
normal practice for this patient population includes a preoperative consultation with an 
anesthesiologist one month prior to surgery.  Development of the algorithm ensured that the 
surgeon ordered a complete blood count, which was then available at this patient visit allowing 
the anesthesiologist time to analyze and implement of the most appropriate strategy to limit the 
use of transfusions based on the calculations. Transfusion-sparing strategies included the use 
preoperative epoetin alfa, prudent use of autologous blood donation, red blood cell salvage, or a 
combination of these strategies resulting in not only cost-neutrality, but in medical and quality 
improvements in care.  
Advocating for patient-specific strategies (PSS), Stulberg and Zadzilka, (2007) outlined 
strategies in the preoperative, intraoperative, and postoperative phases of total joint surgery, 
which can be employed for blood management. Preoperatively, a baseline hemoglobin three 
weeks before surgery is recommended with treatment using epoetin alfa as warranted to boost 
the hemoglobin. They do not recommend autologous donation due to associated preoperative 
anemia, cost, and wastage. Pulling together outlined strategies with a planned blood management 
program for total joint surgeries, they realized PAD decreases of 117 units in 226 patients,  a 
20% drop in transfusion rate, and greater than $50,000 savings in one year (Stulberg & Zadzilka, 
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2007). 
Proposed algorithm.  Figure 4 is the initial algorithm proposed for practice within this 
setting. It is designed to serve as a tool guiding the assessment and management of preoperative 
anemia for elective surgical procedures with an anticipated blood loss of three units of blood or 
greater. The goal is in line with the first pillar identified in blood conservation strategies namely, 
maximizing preoperative red blood cell mass (Gombotz, Rehak, Shander, & Hofmann, 2007).  
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Preoperative 
laboratory 
tests 
including a 
Complete 
Blood Count  
30 days 
before 
elective 
surgery 
 
Anemia Evaluation 
 (Check and document 
indices prior to epoetin 
alfa therapy) 
 
√   Vitamin B12 
√   Folic Acid level 
√   RBC indices 
√   Reticulocyte count 
√   Iron parameters: 
 - Serum iron 
 - TIBC 
 - %Transferrin sat 
 - Serum ferritin 
√Stool occult blood 
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prior to epoetin initiation 
 
If Iron studies 
(TSAT < 20% 
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<100). Replete 
with IV iron prior 
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Macrocytic: 
If ↓ B12 : give  
B12  1000 mcg   
in 4 weekly 
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↓ folate: begin 
Oral folic acid 
Normocytic: 
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monitored 
setting pre op 
day 21, 14 & 7 
Microcytic: 
 ↓ iron studies: 
IV iron  
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GOAL:  Maximize preoperative red blood cells 
      
Figure 4: Algorithm for Assessment and Management of Pre-operative Anemia for 
Elective Surgical Procedures Anticipating Blood Loss of > 3 Units of Blood 
 
 
** Remind patient to stop medications that can hinder coagulation prior to surgery 
as ordered, including prescription, over the counter, and herbal supplements 
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 Key characteristics verified by the literature and the sample surgical patients from the 
study help frame the algorithm. TKA and THA procedures are associated with 3 to 5 grams of 
hemoglobin loss.  Additionally, age, ethnicity, gender, and comorbid conditions can increase the 
likelihood that patients may have preoperative anemia.  Preoperative blood work done thirty days 
before the scheduled surgery that includes a CBC is warranted, so that preoperative anemia can 
be corrected prior to the surgery. This is not a current practice pattern within this particular 
healthcare system.  Results from the patients in the sample demonstrated that timing of the 
preoperative CBC is closer to the surgical procedure than the recommended thirty-day window 
needed to treat noted anemia. Of the 228 patients, 50% had their blood tests completed in a 
window of seven to ten days prior to surgery. Another 44% had their blood tests completed in 
days 11 to 29 days preoperatively. Only 6% had a known preoperative hemoglobin level done 
thirty days prior to surgery. 
If the hemoglobin in noted to be above 13.0g/dL, PAD should not be offered as an option 
with exceptions made for patients with known antibodies and/or those who firmly demand to use 
this process (Kumar, 2009).  The literature demonstrates that this practice is not beneficial due to 
time inefficiencies for patients and the laboratory personnel, associated costs, wastage of the 
units not utilized, and preoperative anemia noted in those who donated in advance of their 
surgical procedure (Bierbaum et al., 1999). 
If the hemoglobin level is below 13.0 g/dL, further studies are warranted to ascertain the 
reason for preoperative anemia. Algorithms used for assessing and treating preoperative anemia 
differentiate the condition using the red blood cell indices, specifically the mean corpuscular 
volume (MCV) to determine if the anemia is macrocytic, microcytic, or normocytic. In 
macrocytic anemia, the MCV is greater than 100 fl suggestive of vitamin B12 or folate 
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deficiency. Microcytic anemia with an MCV less that 80 fl suggests an iron deficiency. 
Normocytic anemia is defined when the MCV is in the 80 to 100 fl range. Supplementing with 
folate, B12, or iron is recommended to correct the anemic condition (Goodnough, et. al 2005). 
If iron deficiency is noted, it can be corrected with intravenous (IV) iron. There are IV 
iron preparations that are safe, efficient, and effective. The IV route of administration is 
recommended when the patient is intolerant of oral iron preparations, or when there is inadequate 
time for oral agents to respond (Cuenca, García-Erce, & Muñoz, 2008). The time to surgery for 
oral iron to be effective is 30 – 45 days (Cuenca, García-Erce, Muñoz, Izuel, Martínez, & 
Herrera, 2004). 
The treatment of preoperative iron deficiency anemia in patients undergoing orthopedic 
surgery was the subject of a prospective study done in Switzerland by Theusinger, Leyvraz, 
Schanz, Seifert, and Spahn (2007). A noted 21% of the patients undergoing elective major 
orthopedic surgeries had iron deficient anemia and were treated with 900 mg of IV iron sucrose 
over the course of ten days four weeks before surgery. A significant increase in hemoglobin was 
noted (p < 0.0001) with the mean maximum increase of 1.0 + 0.6 g/dl. This peak hemoglobin 
was seen two weeks after the initiation of IV iron, but the increase was not sustained throughout 
the surgical episode. Eight of the twenty patients required perioperative transfusions. The authors 
speculate the endogenous erythropoietin decrease, which accompanied the hemoglobin increase, 
is the reason for this response and therefore, recommend the IV iron two weeks preoperatively 
(Theusinger, et al., 2007).  
If normocytic anemia is detected and/or the use of IV iron does not increase the 
hemoglobin above 13.0 g/dL, epoetin alfa (EPO) is recommended. Epoetin alfa is indicated for 
use preoperatively in total joint replacement surgical patients to boost red blood cell production 
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in those patients found to have preoperative anemia. While expensive, this medication has been 
shown to decrease the use of blood transfusions postoperatively in patients who electively have 
THA and TKA surgical procedures (Cushner, Lee, Scuderi, Arsht, & Scott, 2006). Epoetin alfa 
use for preoperative anemia has been studied and is in use globally. 
In one study using EPO (Rosencher, Poisson, Albi, Aperce, Barre, & Samama, 2005) the 
number of EPO injections required to reach a hematocrit of 40% in moderately anemic patients 
was compared to the use of autologous blood donations. This study received  financial support 
from Janssen-Cilag Laboratory and was stimulated by a recommendation from the French 
authorities that allogeneic transfusions be limited to life threatening situations and alternative 
therapeutic strategies be used for all other patient care. Outcomes demonstrated that those 
patients who were given epoetin alfa preoperatively had a higher volume of red blood cell (RBC) 
production, and had a significantly higher hematocrit on days one and three after surgery and at 
discharge. These patients also had better energy scores as measured by questions on fatigue, 
headaches, malaise, nausea, palpitations, and dyspnea, and they required less transfusion. Two 
injections of epoetin alfa were sufficient in most cases to reach goal, thus lowering the associated 
transfusion expenses. While both the use of epoetin alfa and PAD aim to decrease the use of 
allogeneic transfusions, the study noted that interventions should be individualized based on 
erythrocyte volume and predicted total blood loss (Rosencher, et al., 2005). 
In another Canadian study, with grant support from Janssen-Ortho Inc., a random double 
blind multicenter trial was designed to examine two modified dose regimens of epoetin alfa with 
placebo. The factors under study were EPO dosing, the use of allogeneic transfusions, and 
thromboembolic events. The study involved thirteen teaching hospitals, four community 
hospitals, and a patient population that was ineligible for PAD.  A total of 201 THA patients  
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with preoperative hemoglobin levels 98 to 137 grams were assigned to one of three groups. 
Group one was treated with 40,000 units of subcutaneous epoetin alfa preoperatively for four 
weeks. Group two received 20,000 units of epoetin alfa a total of four weeks preoperatively and 
the third group was treated with placebo. All of the patients were given oral iron in the amount of 
450 grams for 42 days or more preoperatively. Hemoglobin levels, reticulocyte counts, and 
doppler studies of lower extremities were compared. This study found that patients who received 
EPO needed significantly less blood and had better hematological responses than those treated 
with placebo. Patients dosed with 40,000 units of EPO had lower transfusion rates than those 
treated with 20,000 units. The incidence of thromboembolic events did not differ (Feagan, et al., 
2000). 
Attempting to study the use of epoetin alfa in the elderly, Lofthouse, Boitano, Davis, and 
Jinnah (2000) compared its use preoperatively for patients seventy years of age or older having 
major elective orthopedic surgeries with a matched group as control. Using an open-label, 
nonrandomized, parallel group study, control patients were matched for age, history, and surgical 
procedures. The study group protocol utilized 40,000 units of EPO given in two doses to patients 
in need of TKA and three doses for those having THA surgery. All patients received oral iron for 
at least fourteen days preoperatively. End  points of the study were pre and postoperative 
hemoglobin and hematocrit levels and transfusion requirements. Transfusion triggers for the 
study remained at 10 g/dL. The study group had 12.5% use of blood transfusions as compared to 
the control group, which had a 74% use of blood transfusions. Epoetin alfa was deemed safe and 
efficient when used preoperatively in the elderly who elective to have TKA or THA according to 
this study, which noted no hematologic complications in the study group (Lofthouse, Boitano, 
Davis, & Jinnah, 2000). 
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Epoetin alfa has an indication for use preoperatively in anemic patients who elect to have 
THA and TKA procedures for the purpose of increasing red blood cell volume. As with all 
medications, there are safety concerns with EPO. In this indication, it is recommended that EPO 
only be used with prophylactic anticoagulation, due to the increased risk of thromboembolic 
events (Kumar, 2009). In one prospective, open-label, randomized study specifically looking at 
the use of EPO in patients with spine surgery without the use of prophylactic anticoagulation, a 
higher rate of deep vein thrombosis was found in those treated with EPO when compared to a 
control group (Stowell, Jones, Enny, Landholff, & Leitz, 2009). One case study further illustrates 
the fact that hemoglobin levels need to be closely monitored while patients are receiving EPO. 
This particular patient was treated both preoperatively and postoperatively with EPO, at 10,000 
units daily as well as prophylactic anticoagulation therapy for her orthopedic surgery. On 
postoperative day eight, with complaints of chest pain, she was transferred to the intensive care 
unit where a hematocrit level of 48% was noted and further tests revealed a ventricular thrombus. 
The authors recommend monitoring of blood counts with the use of EPO (Karabinos, et al., 
2007).  
Interventions to correct preoperative anemia and to maximize red blood cell volume take 
time, assessment skills, and ongoing monitoring. If the assessment reveals guiac positive stools, 
then a gastroenterological workup is warranted. Likewise, in the course of treatment, if the 
patient is not responding with an increasing hemoglobin level, then the team deserves timely 
notification so that other interventions can be ordered. There are anemia management clinics is 
place within this particular healthcare system which are specifically designed to assist the team 
in the management of preoperative anemia. These clinics have standard order sets, utilize point 
of care hemoglobin testing equipment, and are associated with a high level of patient satisfaction. 
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Implications for Practice  
This change project was designed from inquiry between two professionals interested in 
the impact of preoperative anemia on postoperative blood transfusions for patients who 
electively have TKA and THA surgical procedures. Truly, there are opportunities to influence 
patient care with improvements that can make the surgical experience for TKA and THA 
procedures safer and more satisfying. Clinical and technical knowledge regarding these surgical 
procedures continues to evolve. Hence, there is a need for those involved in the care of these 
patients to stay focused on analysis of the research. This analysis should lead to necessary 
practice changes primarily for the sake of patient care, but also to remain competitive in the 
marketplace.  
There are many members of the healthcare team assigned to total joint replacement 
surgeries. It is essential for the team to learn from one another, to form a common ever-
expanding worldview while remaining focused on the value of creating the best patient 
experience. Decision-making, problem solving, and evaluating practice as a team is crucial in 
this rapidly changing healthcare environment. Teams who can accomplish these tasks will set the 
stage for patient care that is clinically excellent and up-to-date, and will therefore remain 
competitive. This study, completed by an advanced practice nurse, is but one example of 
reviewing current practice with the goal of informing the team of opportunities to improve 
patient care for those who elect to have TKA and THA procedures in this healthcare setting.  
Costs and Benefits 
The project would not be complete without attention to the costs and benefits associated 
with the recommended changes in practice. Understanding the financial risk involved in clinical 
change projects is essential in these economically strained times. It is essential to keep in mind 
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that anemia is a multiplier of morbidity and mortality and therefore deserves attention (Kumar, 
2009). The costs and benefits of preoperative medications to correct anemia for elective surgery 
need to be compared to the use of blood transfusions postoperatively. The administration of EPO 
and IV iron preoperatively, appropriately monitored, are safe and effective in increasing red 
blood cells. There are significant expenses associated with the use of these medications.  That 
expense needs to be balanced against the use of blood transfusions for elective surgeries, which 
is a complicated task.  It is hard to get a handle on the exact cost of a unit of allogeneic blood and 
the treatment of potential resulting adverse effects, but the associated monies for a unit of blood 
will increase with further safety testing and shortages.  In looking at the costs of epogen over the 
use of allogeneic transfusions, Keating, Callaghan, Ranawat, Bhirangi and Ranawat (2007) note 
that it would be inappropriate to recommend allogeneic transfusion over EPO simply on the basis 
of direct cost. Blood transfusions may be more costly than blood conservation efforts when the 
calculation includes the risks and scarcity of blood, the liability associated with transfusion 
errors, and the costs of testing, storing, and transfusing blood (Keating, Callaghan, Ranawat, 
Bhirangi & Ranawat 2007, p. 331-332) 
 The case for conserving blood is compelling according to Longjohn, Dorr, McPherson 
(1999); because shortages are common, there is a shrinking donor pool, and surgeries around the 
nation have been canceled due to the unavailability of blood. This necessitates judicious 
utilization. From a safety standpoint, every unit of blood transfused has associated risks, even 
when closely monitored. From an institutional aspect, Joint Commission plans to implement a 
performance measure surrounding blood utilization and conservation necessitating interventions, 
such as a preoperative algorithm to prove compliance (Joint Commission Accreditation of 
Healthcare Organizations, 2007).  
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Conclusion 
 In summary, this particular change project challenges providers engaged in the practice 
of providing care to patients who elect to have TKA or THA surgical procedures to reexamine 
the patient care experience in light of best practices, particularly those related to reducing 
preoperative anemia and postoperative transfusions. There are strategies that can enhance the 
surgical experience, making it safer for patients and more ethically sound and socially just for 
providers.  
Next Steps 
  Moving the change process forward will involve a number of steps. Weaving the Human 
Systems Theory into the change process will be vital to setting the tone for team participation. 
The seven basic human operations of learning, constructing worldview, constructing ideal 
pattern, conceptualization, creating climate, creating environment, and  cybernetics serve to 
establish the human group, the health care team.  Engaging team members to learn from this 
research will take place through a variety of dissemination methods, some written and some oral. 
The research will serve to demonstrate how the worldview can be expanded and practice 
enhanced by incorporating evidence-based knowledge from a global perspective. United in 
professional values to deliver quality, safe, effective, efficient care in a fiscally responsible 
manner within the health care system drives a common ideal pattern for team members. 
Implementation of the algorithm will involve intention, planning, decision-making, problem 
solving, and evaluation, in essence, all of the steps from the human process of conceptualization. 
The work to create a climate and environment, which is conducive to autonomous professionals 
uniting in ongoing collaboration, cannot be underestimated. If this, in fact, is possible the 
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synergy that pours out from such teamwork will ensure achievement of mission, vision, values, 
and sustained marketability for the system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES      49 
References 
Bierbaum, B. E., Callaghan, J. J., Galante, J. O., Rubash, H. E. Tooms, R. E., & Welch, R.B., 
(1999). An analysis of blood management in patients having a total hip of knee 
arthroplasty. The Journal of Bone and Joint Surgery, 81-A (1), 2-10. 
Billote, D.B., Glisson, S.N.,  Green, D., & Wixson. R.L., (2002) A prospective, randomized 
study of preoperative autologous donation for hip replacement surgery. The Journal of 
Bone and Joint Surgery, 84, 1299-1304. 
Boucher, B.A., & Hannon, T.J. (2007). Blood management: A primer for clinicians. 
Pharmacotherapy 27(10), Retrieved from: 
http://www.medscape.com/viewarticle/564606_print 
Callaghan, J.J., O’Rourke, M.R., & Liu, S.S., (2005). Blood management issues and options. The 
Journal of Arthroplasty 20(4) Suppl. 2, 51-54. doi:10.1016/j.artg.2005.03.018 
Cook, J. R., Warren, M., Ganley, K.J., Prefontaine, P., & Wylie, J.W., (2008) A comprehensive 
joint replacement program for total knee arthroplasty: A descriptive study. BMC 
Musculoskeletal Disorders, 9 (154),  doi: 10.1186/147-2474-9-154 
Cuenca, J., García-Erce, J.A., & Muñoz, J. (2008) Efficacy of intravenous iron sucrose 
administration for correcting preoperative anemia in patients scheduled for major 
orthopedic surgery Anesthesiology, 109(1), 151-152. 
Cuenca, J., García-Erce, J.A., Muñoz, J., Izuel, M., Martinez, A.A., & Herrera, A (2004) Patients 
with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: 
A pilot study. Transfusion, 44, 1447-52. 
Cushner, F.D., Lee, G., Scuderi, G.R., Ascht, S.J., & Scott, W.N. (2006). Blood loss 
management in high-risk patients undergoing total knee arthroplasty: A comparison of 
Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES      50 
two techniques. The Journal of Knee Surgery, 19(4), 249-253. 
Diamond, P.T., Conaway, M.R., Mody, S.H., & Bhirangi, K., (2006). Influence of hemoglobin 
levels on inpatient rehabilitation outcomes after total knee arthroplasty. The Journal of 
Arthroplasty, 21(5), 636-641. 
Ershler, W.B., Chen, K., Reyes, E.B., & Dubois, R., (2005). Economic burden of patients with 
anemia in selected diseases. Value in Health, 8(6), 629-638. doi:10.1111/j.1524-
4733.2005.00058.x 
Feagan, B. G., Wong, C. J., Kirkely, A., Johnston, D. W. C., Smith, F. C., Whitsitt, P., …. & 
Lau, C.Y. (2000). Erythropoietin with iron supplementation to prevent allogeneic blood 
transfusion in total hip joint arthroplasty. Annals of Internal Medicine, 133(11), 845-854. 
Retrieved from: www.annals.org.  
Gombotz, H., Rehak, P. H., Shander, A., & Hofmann, A. (2007). Blood use in elective surgery: 
The Austrian benchmark study. Transfusion, 47, 1468-1480. dio: 10.1111.j.1537-
2995.2007.01286.x 
Goodnough, L.T., Shander, A., Spivak, J.L., Waters, J.H., Friedman, A.J., Carson, J.L…, & 
Spence, R. (2005). Detection, evaluation, and management of anemia in the elective 
surgical patient. Anesthesia & Analgesia, 101, 1858-1861. 
doi:10.1213/01.ANE.0000184124.29397.EB 
Goodnough, L.T., Shander, A., and Spence, R. (2003). Bloodless medicine: clinical care without 
allogeneic blood transfusion. Transfusion 43 (19), 668-676. 
Hanlon, J.M. (1968). Administration and education. Belmont, CA: Wadsworth.  
Hatzidakis, A.M., Mendlick, R.M., McKillip, T., Reddy, R.L., & Garvin, K.L. (2000). 
Preoperative autologous donation for total joint arthroplasy. The Journal of Bone and 
Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES      51 
Joint Surgery, 82-A(1), 89 – 100. 
Hepinstall, M.S., Colwell, C.W., & Macaulay, W.B. (2003). Blood conservation in primary hip 
arthroplasty. Journal of the Southern Orthopaedic Association, 12(2), 95-102. 
Holdener, K.E. & Liang, X. (2007). An overview of anemia and its management: What the 
pharmacist need to know. Journal of the Pharmacy Society of Wisconsin, March/ April, 
13-21. 
Joint Commission Accreditation of Healthcare Organizations (2007). Joint commission 
perspectives of patient safety. Joint Commission Resource Publication, 7(1), 1-12. 
Karabinos, I.K., Koulouris, S., Kranidis, A., Ali, M.E., Marsonis, A., Kokkinou, V., & 
Exadaktylos, N. (2007). Spontaneous thrombus formation in a normal left ventricle 
following administration of large doses of epoetin. Hellenic Journal of Cardiology, 48, 
44-46. 
Keating, E.M., Callaghan, J.J., Ranawat, A.S., Bhirangi, K., & Ranawat, C.S. (2007). A 
randomized, parallel-group, open-label trial of recombinant human erythropoietin vs. 
preoperative autologous donation in primary total joint arthroplasty. The Journal of 
Arthroplasty, 22(3), 325-333. doi: 10.1016/j.arth.2006.11.002 
Keating, E.M. & Meding, J.B. (2002). Perioperative blood management practices in elective 
orthopaedic surgery. Journal of the American Academy of Orthopaedic Surgeon’s 10(6), 
393-400. 
Keating, E.M., Meding, J.B., Faris, P.M., & Ritter, M.A. (1998). Predictors of transfusion risk in  
           elective knee surgery. Clinical Orthopaedics and Related Research, 357, 50-59. 
Keating, E,M., & Ritter, M.A. (2002). Transfusion options in total joint arthroplasty. The Journal    
            of Arthroplasty, 17(4), 125-128. doi:10.1054/arth.2002.32459 
Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES      52 
Kickler, T.S. (2003). Editorial: Why “bloodless medicine” and how should we do it? 
Transfusion, 43, 550-551. 
Killip, S., Bennett, J.M., & Chambers, M.D. (2007). Iron deficiency anemia. American Family 
Physician, 75(5), 671-78. Retrieved from: www.aafp.org/afp 
Koch, C.G., Li, L., Sessler, D.I., Figueroa, P., Hoeltge, G. A., Mihaljevic, T., & Blackstone, E.H. 
(2008). Duration of red-cell storage and complications after cardiac surgery. The New 
England Journal of Medicine, 358, 1229-39. 
Kumar, A., (2009). Perioperative management of anemia: limits of blood transfusion and 
alternatives to it. Cleveland Clinic Journal of Medicine, 76, supplement 4, s112-s118. 
Kumar, A.; & Carson, J.L. (2008). Perioperative anemia in the elderly Clinical Geriatric   
   Medicine, 24, 641-648. doi:10.1016/j.cger.2008.07.003  
Lemaire, R. (2008) Strategies for blood management in orthopaedic and trauma surgery The  
Journal of Bone and Joint Surgery (Br,) 90, 1128-36. doi:10.1302/0301-
620X.90B9.21115 
Liang, M.H., Cullen, K.E., Larson, M.G., Thompson, M.S., Schwartz, J., Fossel, A.H., Roberts,  
W.N., & Sledge, C.B. (1986) Cost-effectiveness of total joint arthroplasty in 
osteoarthritis. Arthritis & Rheumatism, 29(8), 937-943. 
Lofthouse, R. A., Boitano, M. A., Davis, J. R., & Jinnah, R. H. (2000). Preoperative 
administration of epoetin alfa to reduce transfusion requirements in elderly patients 
having primary total hip or knee reconstruction. Journal of Southern Orthopaedic 
Association 9(3). Retrieved from: http://www.medscape.com/viewarticle/410438 
Lonner, J.H. & Deirmengian, C.A. (2007). What’s new in adult reconstructive knee surgery The 
Journal of Bone and Joint Surgery, 89(12), 2828-2837. doi:10.2106/JBJS.G.01232 
Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES      53 
Longjohn, D.B., Dorr, L.D. & McPherson, E.J., (1999) Commentary: Blood management 
challenges in revision hip arthroplasty. Orthopedics, 22(1), s148-s150 
Mackenzie, C. R., Miller, F. G., & Fins, J. J. (2005).Justice and health care in the rheumatic 
diseases. Hospital for Special Surgery, 1(1), 58-63. doi: 10.1007/s11420-005-0108-0. 
Retrieved from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504135 
Marks, R., & Allegrante, J. P. (2007). Prevalence and impact of arthritis: Opportunities for 
prevention. Health Education Journal 66(1), 3-21 doi: 10.1177/001789690706936 
Martinez, V., Monsaingeon-Lion, A., Cherif, K., Judet, T., Chauvin, M., & Fletcher, D. (2007). 
 Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to 
lower transfusion rates and hospital costs. British Journal of Anaesthesia, 99(6), 794-800. 
 doi:10.1093/bja/aem266 
Monk, T.G. (2004). Preoperative recombinant human erythropoietin in anemic surgical patients 
Critical Care 8(supplement 2), S45-S48. doi:10.1186/cc2824 
Müller, U., Exadaktylos, A., Roeder, C., Pisan, M., Eggli, S., & Jüni, P. (2004). Quality 
improvement report. Effect of a flow chart on use of blood transfusions in primary total 
hip and knee replacement: prospective before and after study. BMJ, 328, 934-938. doi: 
10.1136/bmj.328.7445.934 
National Anemia Action Council (2009). Frequently asked questions. Retrieved from: 
http://www.anemia.org/patients/faq 
Nel, T.J. (2008). Clinical guidelines, audits and hemovigilance in managing blood transfusion 
needs. Transfusion Alternatives in Transfusion Medicine 10(2), 61-69. Retrieved from: 
http://www.medscape.com/viewarticle/580997_print 
Pierson, J.L., Hannon, T.J., & Earles, D. R. (2004). A blood-conservation algorithm to reduce 
Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES      54 
blood transfusions after total hip and knee arthroplasty. The Journal of Bone and Joint 
Surgery, 86(7), 1512-1518. 
Rosencher, N., Poisson, D., Albi, A., Aperce, M., Barré, J., & Samama, C.M. (2005). Two 
injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic 
surgery. Canadian Journal of Anesthesia, 52(2), 160-165. 
Saleh, E.; McClelland, D.B.L.; Hay, A.; Semple, D., & Walsh, T.S. (2007). Prevalence of 
anaemia before major joint arthroplasty and the potential impact of preoperative 
investigation and correction on perioperative blood transfusions. British Journal of 
Anaesthesia, 99(6), 801-8. doi: 10.1093/bja/aem299 
Sehat, K.R., Evans, R.L., & Newman, J.H. (2004). Hidden blood loss following hip and knee 
arthroplasty. The Journal of Bone and Joint Surgery (Br), 86(4), 561-565. 
doi:10.1302/0301-620X.86B4.14508 
Shander, A. & Goodnough, L.T. (2006). Objectives and limitations of bloodless medical care. 
Current Opinion in Hematology, 13, 462-470. 
Sinnen, M.T. (1981). A theory and model of nursing based on nurturance. (Unpublished masters 
thesis). Marquette University College of Nursing, Milwaukee, WI.  
Slappendel, R., Dirksen, R., Weber, E.W.G., & van der Schaaf, D.B., (2003). An algorithm to 
reduce allogeneic red blood cell transfusions for major orthopedic surgery Acta 
Orthopaedica, 74(5), 569-575. doi:10.1080/00016470310017974 
Spahn, D.R. & Casutt, M. (2000). Eliminating blood transfusions: New aspects and perspectives. 
Anesthesiology, 93(1), 242-55. 
Stowell, C.P., Jones, S.C., Enny, C., Langholff, W., & Leitz, G. (2009). An open-label, 
randomized, parallel-group study of perioperative epoetin alfa versus standard of care for 
Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES      55 
blood conservation in major elective spinal surgery: safety analysis. Spine, 34 (23), 2479-
2485. 
Stulberg, B.N. & Zadzilka, J. D., (2007). Blood management issues: using blood management 
strategies. The Journal of Arthroplasty, 22(4) Suppl. 1, 95-98. 
doi:10.1016/j.arth.2007.03.002 
Theusinger, O.M., Leyvraz, P.F., Schanz, U., Seifert, B., & Spahn, D.R. (2007). Treatment of 
iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits. 
Anesthesiology, 107(6), 923-927. 
Toy, P.T.C.Y., Kaplan, E.B., McVay, P.A., Lee, S.J., Strauss, R.G., Stehling, L.S., and the 
preoperative autologous blood donation study group (1992). Blood loss and replacement 
in total hip arthroplasty: a multicenter study. Transfusion, 32(1), 63-67. 
World Health Organization (2008). Worldwide prevalence of anaemia 1993-2005: WHO global 
database on anaemia. Eds. de Benoist, B. & McLean, E. ISBN 978 92 4 159665 7 
 
 
 
 
 
Running head: ANEMIA MANAGEMENT AND TOTAL JOINT SURGERIES      56 
Appendix A. Codebook. Improving Systems of Care to Manage Preoperative 
Anemia and Postoperative Transfusions in Patients who Elect to have Total Knee or Total 
Hip Surgery 
Data Collection and Coding Sheet Coding directly done to 
computer excel spreadsheet 
Variable  Method of data 
collection 
Data collected by researcher 
Hospital 
 
obtained by IT query SFH (1) EMH (2) SJH (3) 
Last name obtained by IT query OMIT 
First name obtained by IT query OMIT 
Middle name/initial obtained by IT query OMIT 
MRI # obtained by IT query OMIT 
Account # obtained by IT query OMIT 
ID number for de-identified data 
1- 228 
manually created by 
author 
Whole number 1 to 228 
Gender obtained by IT query Female (1) male (2) 
Age obtained by IT query Whole number 
Ethnicity  obtained by IT query Native American (1) 
Asian/Pacific Islander (2) 
African American / Black 
(3) Caucasian / White (4) 
Hispanic (5) unknown (6) 
Pre-operative weight manually extracted Whole number + decimal 
kilograms 
Length of stay obtained by IT query Whole number  
Co morbid conditions 
Cardiac disease manually extracted No (0) yes (1) 
HTN manually extracted No (0) yes (1) 
Rheumatoid arthritis manually extracted No (0) yes (1) 
Diabetes mellitus manually extracted No (0) yes (1) 
Chronic kidney disease manually extracted No (0) yes (1) 
Pulmonary disease manually extracted No (0) yes (1) 
Cancer  manually extracted No (0) yes (1) 
Hematologic disease manually extracted No (0) yes (1) 
Liver disease manually extracted No (0) yes (1) 
GI bleed manually extracted No (0) yes (1) 
Neurologic disease / CVA manually extracted No (0) yes (1) 
Preoperative medications: 
Immunosuppressive agents manually extracted No (0) yes (1) 
Anticoagulation agents manually extracted No (0) yes (1) 
Epoetin alfa manually extracted No (0) yes (1) 
IV or oral iron manually extracted No (0) yes (1) 
IM or oral B12 manually extracted No (0) yes (1) 
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Folic acid manually extracted No (0) yes (1) 
Surgical procedures: 
Total hip (primary) (THA) 
Total knee (primary) (TKA) 
Revision hip (RH) 
Revision knee (RK) 
Bilateral hip (BH) 
Bilateral knee (BK) 
manually extracted 
 
THA (1) 
TKA (2) 
RH (3) 
RK (4) 
BH (5) 
BK (6) 
Orthopedic surgeon 
ID number for de-identified data manually created by 
author 
Whole number 1 through 
Surgery  
Estimated blood loss manually extracted Whole numbers in cc’s 
Type of anesthesia  manually extracted General (0) spinal (1) 
Blood tests 
Preoperative hemoglobin manually extracted Number + decimal 
Preoperative hematocrit manually extracted Whole number (%) 
Timing of preoperative CBC manually extracted 7-10 days (1) 
11-29 days (2) 
30 days or longer (3) 
Unknown (4) 
Post op: 
Day 1 hemoglobin 
 
manually extracted 
 
Number + decimal 
Day 1 hematocrit manually extracted Whole number (%) 
Day 2 hemoglobin manually extracted Number + decimal 
Day 2 hematocrit manually extracted Whole number (%) 
Day 3 hemoglobin manually extracted Number + decimal 
Day 3 hematocrit manually extracted Whole number (%) 
Day 4 hemoglobin manually extracted Number + decimal 
Day 4 hematocrit manually extracted Whole number (%) 
Transfusions  
Preautologous donation number 
of units 
manually extracted Whole number 
Transfused  manually extracted No (0) yes (1) 
Allogeneic  number of units manually extracted Whole number 
Autologous number of units manually extracted Whole number 
Costs  
Insurance  obtained by IT query Self pay (1) Medicare (2) 
Medicaid (3) Workers comp 
(4) Commercial (5) 
managed care (6) 
Charges  obtained by IT query Whole number  
Transfusion charges obtained by IT query Whole number 
reimbursement obtained by IT query Whole number 
 
